Publish in this journal
Journal Information
Vol. 29. Issue 5.
Pages 233-239 (September - October 2018)
Download PDF
More article options
Vol. 29. Issue 5.
Pages 233-239 (September - October 2018)
Clinical Research
Characteristics and prognosis of patients admitted to a hospital emergency department for traumatic brain injury and with anticoagulant or antiplatelet treatment
Características y pronóstico de pacientes ingresados en un servicio de urgencias hospitalario por traumatismo craneoencefálico y con tratamiento anticoagulante o antiagregante
Oriol Yugueroa,
Corresponding author

Corresponding author.
, Marianela Guzmanb, Teresa Castañb, Carles Fornéc, Gisela Galindob,d, Jesus Pujolb,d,e
a Institut de Recerca Biomèdica de Lleida (IRBLLEIDA), Lleida, Spain
b Servei d’Atenció Primària, Regió Sanitària de Lleida, Lleida, Spain
c Unitat de Bioestadística, Institut de Recerca Biomèdica de Lleida (IRBLLEIDA), Lleida, Spain
d Institut Universitari d’Investigació d’Atenció Primaria, IDIAP, Lleida, Spain
e Facultat de Medicina, Universitat de Lleida, Lleida, Spain
Article information
Full Text
Download PDF
Tables (4)
Table 1. Description of the study sample.
Table 2. Bivariate analysis by mortality in the first week.
Table 3. Bivariate analysis by administration of anticoagulant treatment.
Table 4. Bivariate analysis by administration of antiplatelet treatment.
Show moreShow less
Background and objective

To determine mortality and complications of patients with traumatic brain injury (TBI) with antiplatelet or anticoagulant treatment in a hospital emergency department.

Materials and methods

Study of hospital cohorts of the 243 patients who attended with pure TBI to the emergency service of the Arnau de Vilanova University Hospital in Lleida between June 1, 2015 and June 1, 2016. Sociodemographic, clinical and other variables related to clinical management were collected. Presence of complications and in-hospital mortality were registered at 24h, at 48h and one week after TBI.


Overall, 50.2% of patients were men, with median age of 80.8years, and without CT-scan findings at admission in 62.3% of cases. A total of 14 patients died (5.8%). Overall mortality was associated with comorbidity, with knowledge loss and with fluctuation of the Glasgow comma scale in the acute process. Patients treated with anticoagulants (39.5%) or antiplatelet agents (33.3%) were older, with higher degree of dependency and more comorbidity, but did not present more complications. Without reaching statistical significance, higher mortality was observed during the first week in anticoagulated patients (7.3% vs. 4.8%, p=0.585) or with antiplatelet treatment (8.6% vs. 4.3%, p=0.241) with respect to those not treated.


No worse results have been observed in number of complications in patients with TBI treated with anticoagulant or antiplatelet treatment, so clinical management seems appropriate. The higher mortality could be explained by the greater complexity of these patients. It would be necessary to carry out more studies, preferably prospective with follow-up after discharge, in order to establish causal mechanisms between clinical management and mortality or associated complications to TBI.

Traumatic brain injury
Anticoagulant treatment
Antecedentes y objetivo

Determinar la mortalidad y las complicaciones de los pacientes que presentan traumatismo craneoencefálico (TCE) con tratamiento antiagregante o anticoagulante en un servicio de urgencias hospitalario.

Materiales y métodos

Estudio de cohortes hospitalarias de los 243 pacientes que acudieron con TCE puro al servicio de urgencias del Hospital Universitario Arnau de Vilanova de Lleida entre el 1 de junio de 2015 y el 1 de junio de 2016. Se recogieron variables sociodemográficas, clínicas y otras relacionadas con el proceso asistencial. Se registró la presencia de complicaciones y la mortalidad de los pacientes a las 24h, a las 48h y una semana después del TCE.


Un 50,2% de los pacientes fueron hombres, de mediana de edad 80,8años, y sin hallazgos en la TAC al ingreso en el 62,3% de los casos. Fallecieron un total de 14 pacientes (5,8%). La mortalidad global se asoció con la comorbilidad, con la pérdida de conocimiento y con la fluctuación de la escala de coma de Glasgow en el proceso agudo. Los pacientes tratados con anticoagulantes (39,5%) o antiagregantes (33,3%) fueron de mayor edad, mayor grado de dependencia y mayor comorbilidad, pero no presentaron mayor número de complicaciones. Sin alcanzar la significación estadística, se observó mayor mortalidad durante la primera semana en los pacientes anticoagulados (7,3% vs 4,8%, p=0,585) o antiagregados (8,6% vs 4,3%, p=0,241) respecto a los no tratados.


No se han observado peores resultados en complicaciones en los pacientes con TCE tratados con anticoagulantes o antiagregantes, por lo que el manejo clínico parece adecuado. La mayor mortalidad puede ser explicada por la mayor complejidad que caracteriza a estos pacientes. Sería necesario realizar más estudios, preferiblemente prospectivos con seguimiento posterior al alta, para poder establecer mecanismos causales entre el manejo clínico y la mortalidad o las complicaciones asociadas al TCE.

Palabras clave:
Traumatismo craneoencefálico


These are the options to access the full texts of the publication Neurocirugía (English edition)
Member of the Sociedad Española de Neurocirugía

If it is the first time you have accessed you can obtain your credentials by contacting Elsevier Spain in or by calling our Customer Service at902 88 87 40 if you are calling from Spain or at +34 932 418 800 (from 9 to 18h., GMT + 1) if you are calling outside of Spain.

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option ¿I have forgotten my password¿.


If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe to

Neurocirugía (English edition)

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Neurocirugía (English edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?